Literature DB >> 10434065

Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short- and medium-chain fatty acids and xenobiotic carboxylic acids.

D A Vessey1, M Kelley, R S Warren.   

Abstract

Two distinct forms of xenobiotic/medium-chain fatty acid:CoA ligase (XM-ligase) were isolated from human liver mitochondria. They were referred to as HXM-A and HXM-B based on their order of elution from a DEAE-cellulose column. Activity of the two ligases was determined toward 15 different carboxylic acids. HXM-A represented 60-80% of the benzoate activity in the lysate, and kinetic analysis revealed that benzoate was the best substrate (highest V(max)/K(m)). The enzyme also had medium-chain fatty acid:CoA ligase activity. HXM-B had the majority of the hexanoate activity and hexanoate was its best substrate. It was, however, also active toward many xenobiotic carboxylic acids. Comparison of these two human XM-ligases with the previously characterized bovine XM-ligases indicated that they were kinetically distinct. When assayed with benzoic acid as substrate, both HXM-A and HXM-B had an absolute dependence on either Mg(2+) or Mn(2+) for activity. Further, addition of monovalent cation (K(+), Rb(+), or NH(4)(+)) stimulated HXM-A activity by >30-fold and HXM-B activity by 4-fold. For both forms, activity toward straight-chain fatty acids was stimulated less by K(+) than was activity toward benzoate or phenylacetate. A 60 kDa short-chain fatty acid:CoA ligase was also isolated. It had activity toward propionate and butyrate, but not acetate, hexanoate or benzoate. The K(m)(app) values were high but similar for propionate and butyrate (285 microM and 250 microM, respectively) but the V(max)(app) was nearly 6-fold greater with propionate as substrate. While the K(m) values are somewhat high, the enzyme is still more efficient with these substrates than either of the XM-ligases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10434065     DOI: 10.1016/s0304-4165(99)00088-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis.

Authors:  Tin K Mao; Paul A Davis; Joseph A Odin; Ross L Coppel; M Eric Gershwin
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

2.  Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B.

Authors:  Rencia van der Sluis
Journal:  Mol Genet Genomics       Date:  2018-06-14       Impact factor: 3.291

Review 3.  Short- and medium-chain fatty acids in energy metabolism: the cellular perspective.

Authors:  Peter Schönfeld; Lech Wojtczak
Journal:  J Lipid Res       Date:  2016-04-14       Impact factor: 5.922

4.  Oncogenic ACSM1 in prostate cancer is through metabolic and extracellular matrix-receptor interaction signaling pathways.

Authors:  Yongchen Guo; Chunna Ren; Wentao Huang; Wancai Yang; Yonghua Bao
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

5.  Expression of Acsm2, a kidney-specific gene, parallels the function and maturation of proximal tubular cells.

Authors:  Hirofumi Watanabe; Robert L Paxton; Matthew R Tolerico; Vidya K Nagalakshmi; Shinji Tanaka; Mark D Okusa; Shin Goto; Ichiei Narita; Seiji Watanabe; Maria Luisa S Sequeira-Lοpez; R Ariel Gomez
Journal:  Am J Physiol Renal Physiol       Date:  2020-08-24

Review 6.  Pharmacogenetic considerations with dichloroacetate dosing.

Authors:  Margaret O James; Peter W Stacpoole
Journal:  Pharmacogenomics       Date:  2016-05-04       Impact factor: 2.533

Review 7.  The glycine deportation system and its pharmacological consequences.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Pharmacol Ther       Date:  2012-05-11       Impact factor: 12.310

8.  Contribution towards a Metabolite Profile of the Detoxification of Benzoic Acid through Glycine Conjugation: An Intervention Study.

Authors:  Cindy Irwin; Mari van Reenen; Shayne Mason; Lodewyk J Mienie; Johan A Westerhuis; Carolus J Reinecke
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

9.  A Single LC-MS/MS Analysis to Quantify CoA Biosynthetic Intermediates and Short-Chain Acyl CoAs.

Authors:  Anthony E Jones; Nataly J Arias; Aracely Acevedo; Srinivasa T Reddy; Ajit S Divakaruni; David Meriwether
Journal:  Metabolites       Date:  2021-07-21

10.  Impaired mitochondrial medium-chain fatty acid oxidation drives periportal macrovesicular steatosis in sirtuin-5 knockout mice.

Authors:  Eric S Goetzman; Sivakama S Bharathi; Yuxun Zhang; Xue-Jun Zhao; Steven F Dobrowolski; Kevin Peasley; Sunder Sims-Lucas; Satdarshan P Monga
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.